人福医药：12月5日召开董事会会议

Group 1 - The core point of the article is that Renfu Pharmaceutical (SH 600079) held its 11th fourth board meeting on December 5, 2025, to discuss the establishment of a legal compliance management system [1] - For the year 2024, Renfu Pharmaceutical's revenue composition is as follows: pharmaceuticals account for 56.01%, pharmaceutical wholesale and related businesses account for 43.8%, and other businesses account for 0.19% [1] - As of the time of reporting, Renfu Pharmaceutical has a market capitalization of 30.4 billion yuan [1]